| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 4,493,000 | 4,597,900 | 4,998,200 | 5,006,200 | | Cost of Revenue | 3,039,000 | 3,143,300 | 3,535,000 | 3,521,700 | | | Gross Profit | 1,454,000 | 1,454,600 | 1,463,200 | 1,484,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 826,000 | 811,300 | 853,700 | 827,600 | | Non Recurring |
-
| 20,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 628,000 | 623,300 | 609,500 | 656,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,000 | 15,400 | 14,900 | 600 | | Earnings Before Interest And Taxes | 636,000 | 638,700 | 624,400 | 657,500 | | Interest Expense | 73,000 | 81,000 | 75,500 | 72,800 | | Income Before Tax | 563,000 | 557,700 | 548,900 | 584,700 | | Income Tax Expense | 164,000 | 124,300 | 154,500 | 174,600 | | Minority Interest |
-
| (35,300) | (34,000) | (34,100) | | | | Net Income From Continuing Ops | 431,000 | 419,600 | 413,100 | 424,400 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
| (300) |
-
| (7,700) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 431,000 | 419,300 | 413,100 | 416,700 | | Preferred Stock And Other Adjustments | (24,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $407,000 | $419,300 | $413,100 | $416,700 |
|
0.45% Nasdaq 
0.20%
Income Statement
